Regulatory

Regulatory

Navamedic to own a total of 96.33 per cent of shares in Sensidose following closing of public offer

Navamedic publishes a supplement to the offer document regarding the unconditional cash offer to the shareholders and holders of warrants of series TO 1 in Sensidose Aktiebolag

Navamedic publishes a supplement to the offer document regarding the unconditional cash offer to the shareholders and holders of warrants of series TO 1 in Sensidose Aktiebolag

Navamedic ASA: Notice of Annual General Meeting

Navamedic ASA Q1 2023: Another strong quarter

Navamedic increases the consideration to SEK 8.50 in cash per share in its unconditional public offer and convenes an extraordinary general meeting of Sensidose Aktiebolag